UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

~~Washington~~WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER ~~PURSUANT TO RULE 13a-16~~

ORPURSUANT ~~15d~~TO RULE 13a-16 ~~UNDER~~OR ~~THE SECURITIES EXCHANGE ACT OF 1934~~15d-16

~~For~~UNDER ~~the~~THE ~~month~~SECURITIES ofEXCHANGE ~~January~~ACT ~~2026~~OF 1934

For the month of February 2026

Commission File Number: 001-40884

ARBE ROBOTICS LTD.

(Translation of registrant’s name into English)

HaHashmonaim St. 107

Tel Aviv-Yafo, Israel

Tel: +972-73-7969804, ext. 200

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

INFORMATION CONTAINED IN THIS CURRENT REPORT ON FORM 6-K

~~Underwriting~~On ~~Agreement~~February 10, 2026, Arbe Robotics Ltd. (the “Company”) issued a press release announcing that it will hold host a live conference call on Thursday, February 26, 2926, at 8:30 a.m. Eastern Time to discuss the Company’s financial results for the fourth quarter 2025 and the full year 2025. The press release is furnished as Exhibit 99.1 to this Report on Form 6-K.

OnSpeakers ~~January~~will ~~26,~~include ~~2026~~Kobi Marenko, ~~Arbe~~co-founder ~~Robotics~~and ~~Ltd.~~chief ~~(“Arbe”~~executive orofficer, ~~the~~and ~~“Company”)~~Karine Pinto-Flomenboim, ~~commenced~~chief anfinancial ~~underwritten~~officer. ~~registered~~Interested ~~direct~~persons ~~offering~~can ~~(the~~register ~~“Offering”)~~in advance at https://dpregister.com/sreg/10206698/103522e5a54. ofLog-in ~~13,225,000~~instructions (will be available upon registering for the ~~“Firm~~event. ~~Shares”)~~Participants ~~ordinary~~may ~~shares~~register at any time, ~~par~~including ~~value~~up ~~NIS~~to 0and after the call start time.~~000216~~ ~~per~~The ~~share,~~live ofcall ~~the~~may ~~Company~~be (accessed via telephone toll free in the ~~“Ordinary~~United ~~Shares”) including~~States at 1 (844) 481-3015,~~725,000~~ ~~Ordinary~~toll-free ~~Shares~~in ~~issued~~Israel at ~~pursuant~~1-809-212-373 toand ~~the~~toll-free ~~full~~internationally ~~exercise~~at of+1 ~~the~~(412) ~~over~~317-~~allotment~~1880 ~~option~~internationally. ~~(the~~The ~~“Optional~~call ~~Shares”~~ will be webcast live and, ~~together~~accessible ~~with~~from a ~~the~~link ~~Firm~~Arbe’s ~~Shares,~~Investor ~~the~~Relations ~~“Shares”)~~website at: https://ir.arberobotics.com. ~~The~~An ~~public~~archived ~~offer~~webcast ~~price~~of ~~for~~the ~~each~~conference ~~Share~~call ~~was~~can $1be accessed at Arbe’s Investor Relations website at: https://ir.40arberobotics.com on the day following the call.

~~Canaccord~~Cautionary ~~Genuity~~Note ~~acted~~Regarding ~~as the sole bookrunner for the Offering, with Roth Capital Partners and WestPark Capital acting as co~~Forward-~~managers~~Looking ~~for the Offering.~~Statements

~~The~~This ~~gross~~Current ~~proceeds~~Report ~~from~~on Form 6-K (“report”) including its Exhibit 99.1 contains, and the ~~Offering~~conference call described in this report will contain, ~~before~~“forward-looking ~~deducting~~statements” ~~underwriting~~within ~~discounts~~the ~~and~~meaning ~~commissions~~of the Securities Act of 1933 and ~~offering~~the ~~expenses~~Securities ~~payable~~Exchange Act of 1934, both as amended by the ~~Company~~Private Securities Litigation Reform Act of 1995. The words “expect,” ~~described~~“believe,” in“estimate,” ~~more~~“intend,” ~~detail~~“plan,” “anticipate,” ~~below~~“may,” ~~were~~“should,” ~~approximately~~“strategy,” ~~$18.5~~“future,” ~~million~~“will,” “project,” “potential” and similar expressions indicate forward-looking statements. Forward-looking statements are predictions, projections ~~The~~and ~~Company~~other ~~intends~~statements about future events that are based on current expectations and assumptions and, as a result, are subject to ~~use~~risks and uncertainties. These risks and uncertainties include the ~~net~~effect ~~proceeds~~of tariffs and trade policies of the United States, China and other countries, whether announced or implemented; the effect on the Israeli economy generally and on the Company’s business resulting from the terrorism and the ~~Offering~~hostilities ~~for~~in Israel and with its neighboring countries including the effects of the continuing war with Hamas in Gaza and any intensification of hostilities with others, including Iran and Hezbollah, and the effect of the call-up of a significant portion of its working ~~capital~~population, including the Company’s employees; the effect of any potential boycott both of Israeli products and business ~~general~~and ~~corporate~~of ~~purposes~~stocks in Israeli companies; the effect of any downgrading of the Israeli economy and the effect of changes in the exchange rate between the US dollar and the Israeli shekel; and the risk and uncertainties described in “Cautionary Note Regarding Forward-Looking Statements,” “Item 3. ~~The~~Key ~~Offering~~Information is– ~~anticipated~~D. Risk Factors” and “Item 5. Operating and Financial Review and Prospects” toand ~~close~~in the Company’s Annual Report on ~~January~~Form 2720-F for the year ended December 31, ~~2026~~2024, which was filed with the Securities and Exchange Commission (the “~~Closing~~SEC”) on March 28, 2025, as well as other documents filed by the Company with the SEC. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements. Forward-looking statements relate only to the date they were made, and the Company does not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made except as required by law or applicable regulation.

Information contained on, or that can be accessed through, the Company’s website or any other website or any social media is expressly not incorporated by reference into and is not a part of this report.

InExhibit Connection with the Offering, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with Canaccord Genuity LLC as representative (the “Representative”) of the underwriters named therein. Pursuant to the Underwriting Agreement, the Company has agreed not to issue, enter into any agreement to issue or announce the issuance or proposed issuance of any Ordinary Shares or any securities convertible into, or exercisable or exchangeable for, Ordinary Shares, including the filing of a registration statement with the Securities and Exchange Commission (“SEC”) in respect thereof, subject to certain exceptions in each instance, for a period of ninety (90) days following the Closing.Index

The Underwriting Agreement contains customary representations, warranties, covenants and agreements by the Company, indemnification obligations of the Company, including for liabilities arising under the Securities Act of 1933, as amended (the “Securities Act”), other obligations of the parties and termination provisions. The representations, warranties and covenants contained in the Underwriting Agreement were made only for the purposes of such agreement and as of specific dates, were solely for the benefit of the parties to such agreement and may be subject to limitations agreed upon by the contracting parties.

Exhibit No.		Document Description
99.1		Press Release dated February 10, 2026

Pursuant to the Underwriting Agreement, the Company has agreed to pay the underwriters underwriting commissions and discounts equal to 6.0% of the gross proceeds of the Offering, including the additional gross proceeds from the underwriters’ exercise of their option to purchase additional shares, and reimbursement of expenses equal to $125,000.

The Shares were offered by the Company pursuant to a registration statement on Form F-3 (File No. 333-287805) originally filed on June 5, 2025, with the SEC under the Securities Act and declared effective by the SEC on June 13, 2025. The foregoing description of the Underwriting Agreement is not complete and is qualified in its entirety by reference to the full text of the Underwriting Agreement, a copy of which is filed as Exhibit 1.1 to this report on Form 6-K and is incorporated herein by reference.

Events

On January 26, 2026, the Company issued a press release announcing the Offering. A copy of the press release is attached as Exhibit 99.1 to this Report on Form 6-K and is hereby incorporated by reference herein.

INCORPORATION BY REFERENCE

This report on Form 6-K, including the exhibits to this report on Form 6-K, shall be deemed to be incorporated by reference into the registration statements on Form F-3 (Registration Numbers 333-280319, 333-269235, 333-284158, 333-287805 and 333-292838) and Form S-8 (File No. 333-280320, 333-269230 and 333-286466) of Arbe Robotics Ltd., and to be a part thereof from the date on which this Report on Form 6-K is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

EXHIBIT INDEX

Exhibit Number		Description
1.1		Underwriting Agreement dated January 26, 2026
5.1		Opinion of Erdinast, Ben Nathan, Toledano & Co.
99.1		Press Release, dated January 26, 2026

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Arbe Robotics Ltd.
	ARBE ROBOTICS LTD.
Date: January 27, 2026	By:	/s/ Jacob (Kobi) Marinka
Date: February 10, 2026	By:	/s/ Kobi Marenko
	Name:	~~Name:~~Kobi Marenko	~~Jacob (Kobi) Marinka~~
	Title:	~~Title:~~CEO	~~Chief Executive Officer~~

4 3

Filing Compare · Arbe Robotics Ltd.